The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Oxidative damage in multiple sclerosis lesions
Open accessAbstract
Multiple sclerosis is a chronic inflammatory disease of the central nervous system, associated with demyelination and neurodegeneration. The mechanisms of tissue injury are currently poorly understood, but recent data suggest that mitochondrial injury may play an important role in this process. Since mitochondrial injury can be triggered by reactive oxygen and nitric oxide species, we analysed by immunocytochemistry the presence and cellular location of oxidized lipids and oxidized DNA in lesions and in normal-appearing white matter of 30 patients with multiple sclerosis and 24 control patients without neurological disease or brain lesions. As reported before in biochemical studies, oxidized lipids and DNA were highly enriched in active multiple sclerosis plaques, predominantly in areas that are defined as initial or 'prephagocytic' lesions. Oxidized DNA was mainly seen in oligodendrocyte nuclei, which in part showed signs of apoptosis. In addition, a small number of reactive astrocytes revealed nuclear expression of 8-hydroxy-d-guanosine. Similarly, lipid peroxidation-derived structures (malondialdehyde and oxidized phospholipid epitopes) were seen in the cytoplasm of oligodendrocytes and some astrocytes. In addition, oxidized phospholipids were massively accumulated in a fraction of axonal spheroids with disturbed fast axonal transport as well as in neurons within grey matter lesions. Neurons stained for oxidized phospholipids frequently revealed signs of degeneration with fragmentation of their dendritic processes. The extent of lipid and DNA oxidation correlated significantly with inflammation, determined by the number of CD3 positive T cells and human leucocyte antigen-D expressing macrophages and microglia in the lesions. Our data suggest profound oxidative injury of oligodendrocytes and neurons to be associated with active demyelination and axonal or neuronal injury in multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citationRelapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citationMultiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Self-citationMitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 841
Distribution and fatty acid composition of phosphoglycerides in normal human brain
Svennerholm, L. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42702-6 · Cited by 639
Cited by
Immunopathology of multiple sclerosis
Dendrou, C. A., Fugger, L., & Friese, M. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3871 · Cited by 2,215
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Self-citationLassmann, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028936 · Cited by 937
Self-citationLoss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684
“Previous studies in multiple sclerosis demonstrated the expression of molecules involved in phagocytosis, antigen presentation and cytotoxicity in active lesions (Brück et al., 1995; Höftberger et al., 2004; Haider et al., 2011; Fischer et al., 2012).”
Self-citationBuendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Hemmer, B., Kerschensteiner, M., & Korn, T. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70305-9 · Cited by 584
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Correale, J., Gaitán, M. I., Ysrraelit, M. C., & Fiol, M. P. (2016) · Brain · doi:10.1093/brain/aww258 · Cited by 573
Davalos, D., Kyu Ryu, J., Merlini, M., Baeten, K. M., Le Moan, N., Petersen, M. A., Deerinck, T. J., Smirnoff, D. S., Bedard, C., Hakozaki, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2230 · Cited by 568
Self-citationOxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
Que, X., Hung, M.-Y., Yeang, C., Gonen, A., Prohaska, T. A., Sun, X., Diehl, C., Määttä, A., Gaddis, D. E., Bowden, K., et al. (2018) · Nature · doi:10.1038/s41586-018-0198-8 · Cited by 529
Self-citationIron and neurodegeneration in the multiple sclerosis brain
Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Brück, W., & Lassmann, H. (2013) · Annals of Neurology · doi:10.1002/ana.23974 · Cited by 519
Self-citationFischer, M. T., Sharma, R., Lim, J. L., Haider, L., Frischer, J. M., Drexhage, J., Mahad, D., Bradl, M., van Horssen, J., & Lassmann, H. (2012) · Brain · doi:10.1093/brain/aws012 · Cited by 507
Self-citationThe role of interleukin-6 signaling in nervous tissue
Rothaug, M., Becker-Pauly, C., & Rose-John, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.03.018 · Cited by 491
“[131] also contribute to myelin sheath damage due to their toxic effects on oligodendrocytes [132].”
BackgroundSlow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
Dal-Bianco, A., Grabner, G., Kronnerwetter, C., Weber, M., Höftberger, R., Berger, T., Auff, E., Leutmezer, F., Trattnig, S., Lassmann, H., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1636-z · Cited by 463
“Mitochondrial DNA deletions, oxidative stress [20], and iron accumulation and its liberation during demyelination [21] are thought to be key factors of neurodegeneration in progressive MS [28].”
BackgroundSelf-citationSolleiro-Villavicencio, H., & Rivas-Arancibia, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00114 · Cited by 463
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Faissner, S., Plemel, J. R., Gold, R., & Yong, V. W. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0035-2 · Cited by 459
NADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
Haider, L., Zrzavy, T., Hametner, S., Höftberger, R., Bagnato, F., Grabner, G., Trattnig, S., Pfeifenbring, S., Brück, W., & Lassmann, H. (2016) · Brain · doi:10.1093/brain/awv398 · Cited by 400
Self-citationHaider, L., Simeonidou, C., Steinberger, G., Hametner, S., Grigoriadis, N., Deretzi, G., Kovacs, G. G., Kutzelnigg, A., Lassmann, H., & Frischer, J. M. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307712 · Cited by 357
Self-citationOxidative stress in multiple sclerosis: Central and peripheral mode of action
Ohl, K., Tenbrock, K., & Kipp, M. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2015.11.010 · Cited by 317
Disease-specific molecular events in cortical multiple sclerosis lesions
Fischer, M. T., Wimmer, I., Höftberger, R., Gerlach, S., Haider, L., Zrzavy, T., Hametner, S., Mahad, D., Binder, C. J., Krumbholz, M., et al. (2013) · Brain · doi:10.1093/brain/awt110 · Cited by 311
“degenerating oligodendrocytes and axons (Haider et al., 2011), the increased expression of molecules involved in antioxidant defence (van Horssen et al.”
BackgroundInfluentialSelf-citationRedox Control of Microglial Function: Molecular Mechanisms and Functional Significance
Rojo, A. I., McBean, G., Cindric, M., Egea, J., López, M. G., Rada, P., Zarkovic, N., & Cuadrado, A. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5745 · Cited by 309
Pathology of multiple sclerosis and related inflammatory demyelinating diseases
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 303
Oxidative and nitrative stress in neurodegeneration
Cobb, C. A., & Cole, M. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.020 · Cited by 298
The molecular basis of neurodegeneration in multiple sclerosis
Lassmann, H., & van Horssen, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.004 · Cited by 294
Self-citationTreatment of progressive multiple sclerosis: what works, what does not, and what is needed
Feinstein, A., Freeman, J., & Lo, A. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70231-5 · Cited by 281
New Insights on NOX Enzymes in the Central Nervous System
Nayernia, Z., Jaquet, V., & Krause, K.-H. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5703 · Cited by 279
Neuroprotection and repair in multiple sclerosis
Franklin, R. J. M., ffrench-Constant, C., Edgar, J. M., & Smith, K. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.200 · Cited by 278
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D. J., Lassmann, H., & van Horssen, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 278
Self-citationPathology and disease mechanisms in different stages of multiple sclerosis
Lassmann, H. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.010 · Cited by 224
Self-citationFibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
Ryu, J. K., Rafalski, V. A., Meyer-Franke, A., Adams, R. A., Poda, S. B., Rios Coronado, P. E., Pedersen, L. Ø., Menon, V., Baeten, K. M., Sikorski, S. L., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0232-x · Cited by 213
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191
“, 2005) mainly in oligodendrocytes and myelin (Fig. 1f; Haider et al., 2011).”
BackgroundInfluentialSelf-citationThe role of microglia in multiple sclerosis
Luo, C., Jian, C., Liao, Y., Huang, Q., Wu, Y., Liu, X., Zou, D., & Wu, Y. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s140634 · Cited by 187
Microglia in multiple sclerosis: protectors turn destroyers
Yong, V. W. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.023 · Cited by 185
Dong, Y., D’Mello, C., Pinsky, W., Lozinski, B. M., Kaushik, D. K., Ghorbani, S., Moezzi, D., Brown, D., Melo, F. C., Zandee, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00801-z · Cited by 181
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
Oligodendrocytes and the early multiple sclerosis lesion
Prineas, J. W., & Parratt, J. D. E. (2012) · Annals of Neurology · doi:10.1002/ana.23634 · Cited by 149
Patejdl, R., Penner, I. K., Noack, T. K., & Zettl, U. K. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.11.005 · Cited by 141
Kumar, P., Lim, A., Hazirah, S. N., Chua, C. J. H., Ngoh, A., Poh, S. L., Yeo, T. H., Lim, J., Ling, S., Sutamam, N. B., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01095-5 · Cited by 142
Dulamea, A. O. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47861-6_7 · Cited by 128
Singh, S., Dallenga, T., Winkler, A., Roemer, S., Maruschak, B., Siebert, H., Brück, W., & Stadelmann, C. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0831-8 · Cited by 118
DNA damage in the oligodendrocyte lineage and its role in brain aging
Tse, K.-H., & Herrup, K. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.05.006 · Cited by 108
“OLs in the plaque suffer extensive oxidative damage to their DNA as detected by enhanced levels of 8-hydroxyguanine, the most common DNA oxidative lesion (Haider et al., 2011).”
BackgroundAlbumin and multiple sclerosis
LeVine, S. M. (2016) · BMC Neurology · doi:10.1186/s12883-016-0564-9 · Cited by 105
Nijland, P. G., Witte, M. E., van het Hof, B., van der Pol, S., Bauer, J., Lassmann, H., van der Valk, P., de Vries, H. E., & van Horssen, J. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0170-2 · Cited by 96
Self-citationDraheim, T., Liessem, A., Scheld, M., Wilms, F., Weißflog, M., Denecke, B., Kensler, T. W., Zendedel, A., Beyer, C., Kipp, M., et al. (2016) · Glia · doi:10.1002/glia.23058 · Cited by 95
GM‐CSF promotes migration of human monocytes across the blood brain barrier
Vogel, D. Y. S., Kooij, G., Heijnen, P. D. A. M., Breur, M., Peferoen, L. A. N., van der Valk, P., de Vries, H. E., Amor, S., & Dijkstra, C. D. (2015) · European Journal of Immunology · doi:10.1002/eji.201444960 · Cited by 94
Oxidative Glial Cell Damage Associated with White Matter Lesions in the Aging Human Brain
Al‐Mashhadi, S., Simpson, J. E., Heath, P. R., Dickman, M., Forster, G., Matthews, F. E., Brayne, C., Ince, P. G., Wharton, S. B., & Medical Research Council Cognitive Function and Ageing Study (2015) · Brain Pathology · doi:10.1111/bpa.12216 · Cited by 85
Cervantes-Llanos, M., Lagumersindez-Denis, N., Marín-Prida, J., Pavón-Fuentes, N., Falcon-Cama, V., Piniella-Matamoros, B., Camacho-Rodríguez, H., Fernández-Massó, J. R., Valenzuela-Silva, C., Raíces-Cruz, I., et al. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.032 · Cited by 73
Pentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73
Hendrickx, D. A. E., Koning, N., Schuurman, K. G., Strien, M. E. V., Eden, C. G. V., Hamann, J., & Huitinga, I. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827fd9e8 · Cited by 72
Oxidized phospholipids as novel mediators of neurodegeneration
Dong, Y., & Yong, V. W. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.03.002 · Cited by 69
iPS-derived neural progenitor cells from PPMS patients reveal defect in myelin injury response
Nicaise, A. M., Banda, E., Guzzo, R. M., Russomanno, K., Castro-Borrero, W., Willis, C. M., Johnson, K. M., Lo, A. C., & Crocker, S. J. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2016.11.012 · Cited by 64
“Within MS lesions DNA damage has been observed (Haider et al., 2011).”
BackgroundGatto, N., Dos Santos Souza, C., Shaw, A. C., Bell, S. M., Myszczynska, M. A., Powers, S., Meyer, K., Castelli, L. M., Karyka, E., Mortiboys, H., et al. (2021) · Aging Cell · doi:10.1111/acel.13281 · Cited by 58
“Strikingly, in the present report, we found that old iNPC-As exhibited a higher baseline level of ROS and DNA damage compared to young iNPC-As.”
BackgroundInfluentialTse, K., Cheng, A., Ma, F., & Herrup, K. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.11.010 · Cited by 56
“As differentiating OLs are poorly defended against oxidative stress due to their low expression of glutathione-related antioxidants [72,84,85] (Supplementary Fig.”
BackgroundThe contribution of neuropathology to multiple sclerosis research
Lassmann, H. (2022) · European Journal of Neurology · doi:10.1111/ene.15360 · Cited by 55
Self-citationFerroptosis induces detrimental effects in chronic EAE and its implications for progressive MS
Jhelum, P., Zandee, S., Ryan, F., Zarruk, J. G., Michalke, B., Venkataramani, V., Curran, L., Klement, W., Prat, A., & David, S. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01617-7 · Cited by 49
Bellizzi, M. J., Geathers, J. S., Allan, K. C., & Gelbard, H. A. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1171-15.2016 · Cited by 41
“Immunostaining with the E06 monoclonal antibody, which has been used to detect oxidized phospholipids in multiple cell types in the MS brain (Haider et al., 2011), showed an increase in oxidized phospholipids in EAE hippocampi (1.”
BackgroundMethodInfluentialOligodendrocyte Maturation Alters the Cell Death Mechanisms That Cause Demyelination
Chapman, T. W., Kamen, Y., Piedra, E. T., & Hill, R. A. (2024) · The Journal of Neuroscience · doi:10.1523/jneurosci.1794-23.2024 · Cited by 33
Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging
Dong, Y., Jain, R. W., Lozinski, B. M., D’Mello, C., Visser, F., Ghorbani, S., Zandee, S., Brown, D. I., Prat, A., Xue, M., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00205-z · Cited by 32
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis
Jokubaitis, V. G., Gresle, M. M., Kemper, D. A., Doherty, W., Perreau, V. M., Cipriani, T. L., Jonas, A., Shaw, G., Kuhlmann, T., Kilpatrick, T. J., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-32 · Cited by 31
Chrzanowski, U., Bhattarai, S., Scheld, M., Clarner, T., Fallier-Becker, P., Beyer, C., Rohr, S. O., Schmitz, C., Hochstrasser, T., Schweiger, F., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.005 · Cited by 18
Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model
Tahmasebi, F., Barati, S., & Kashani, I. R. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102179 · Cited by 17
White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
García-Domínguez, M. (2025) · Cells · doi:10.3390/cells14181408 · Cited by 13
“8-OHdG accumulate in mtDNA, leading to point mutations, deletions, and impaired transcription of ETC subunits, thereby perpetuating mitochondrial dysfunction in a feed-forward loop [156].”
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
Infrared spectral profiling of demyelinating activity in multiple sclerosis brain tissue
Gakh, O., Wilkins, J. M., Guo, Y., Popescu, B. F., Weigand, S. D., Kalinowska-Lyszczarz, A., & Lucchinetti, C. F. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01854-4 · Cited by 4
“Peroxidation of unsaturated lipids has been linked to the pathogenesis of neurodegenerative diseases [49], and Haider and colleagues demonstrated increased oxidized DNA and lipids in active and inactive lesions, PPWM, and NAWM of MS brain tissue using immunohistochemical markers of oxidation [22].”
Background
Metadata
- Authors
- Haider, L., Fischer, M. T., Frischer, J. M., Bauer, J., Hoftberger, R., Botond, G., Esterbauer, H., Binder, C. J., Witztum, J. L., & Lassmann, H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-06-07
- Volume
- 134
- Issue
- 7
- Pages
- 1914-1924
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2090777067
- Cited by
- 753
- References
- 51
- FWCI
- 33.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.